Potential New Non-Invasive Therapy Using Artificial Oxygen Carriers for Pre-Eclampsia
AbstractThe molecular mechanisms of pre-eclampsia are being increasingly clarified in animals and humans. With the uncovering of these mechanisms, preventive therapy strategies using chronic infusion of adrenomedullin, vascular endothelial growth factor-121 (VEGF-121), losartan, and sildenafil have been proposed to block narrow spiral artery formation in the placenta by suppressing related possible factors for pre-eclampsia. However, although such preventive treatments have been partly successful, they have failed in ameliorating fetal growth restriction and carry the risk of possible side-effects of drugs on pregnant mothers. In this study, we attempted to develop a new symptomatic treatment for pre-eclampsia by directly rescuing placental ischemia with artificial oxygen carriers (hemoglobin vesicles: HbV) since previous data indicate that placental ischemia/hypoxia may alone be sufficient to lead to pre-eclampsia through up-regulation of sFlt-1, one of the main candidate molecules for the cause of pre-eclampsia. Using a rat model, the present study demonstrated that a simple treatment using hemoglobin vesicles for placental ischemia rescues placental and fetal hypoxia, leading to appropriate fetal growth. The present study is the first to demonstrate hemoglobin vesicles successfully decreasing maternal plasma levels of sFlt-1 and ameliorating fetal growth restriction in the pre-eclampsia rat model (p < 0.05, one-way ANOVA). In future, chronic infusion of hemoglobin vesicles could be a potential effective and noninvasive therapy for delaying or even alleviating the need for Caesarean sections in pre-eclampsia. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Ohta, H.; Kaga, M.; Li, H.; Sakai, H.; Okamura, K.; Yaegashi, N. Potential New Non-Invasive Therapy Using Artificial Oxygen Carriers for Pre-Eclampsia. J. Funct. Biomater. 2017, 8, 32.
Ohta H, Kaga M, Li H, Sakai H, Okamura K, Yaegashi N. Potential New Non-Invasive Therapy Using Artificial Oxygen Carriers for Pre-Eclampsia. Journal of Functional Biomaterials. 2017; 8(3):32.Chicago/Turabian Style
Ohta, Hidenobu; Kaga, Maiko; Li, Heng; Sakai, Hiromi; Okamura, Kunihiro; Yaegashi, Nobuo. 2017. "Potential New Non-Invasive Therapy Using Artificial Oxygen Carriers for Pre-Eclampsia." J. Funct. Biomater. 8, no. 3: 32.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.